NATURE’S SUNSHINE PRODUCTS, INC. Amortization of Debt Discount (Premium)
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2017-03-14
- NATURE’S SUNSHINE PRODUCTS, INC. amortization of debt discount (premium) for the quarter ending 2014-12-31 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. amortization of debt discount (premium) for the quarter ending 2014-09-30 was $2.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. amortization of debt discount (premium) for the quarter ending 2014-06-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. amortization of debt discount (premium) for the quarter ending 2014-03-31 was $1.00K, a 0.00% change year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. amortization of debt discount (premium) for fiscal 2016 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. amortization of debt discount (premium) for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- NATURE’S SUNSHINE PRODUCTS, INC. amortization of debt discount (premium) for fiscal 2014 was $3.00K, a 200.00% increase from fiscal 2013.
- NATURE’S SUNSHINE PRODUCTS, INC. amortization of debt discount (premium) for fiscal 2013 was $1.00K, a 88.89% decline from fiscal 2012.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-14 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-14 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $2.00K derived: sum of 2 quarters · filed 2017-03-14 | $2.00K derived: sum of 3 quarters · filed 2017-03-14 | $3.00K 10-K · filed 2017-03-14 |
| 2014-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $2.00K derived: sum of 2 quarters · filed 2015-11-06 | $3.00K 10-Q · filed 2015-11-06 | $3.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.00K 10-Q · filed 2015-08-10 | $1.00K derived: sum of 3 quarters · filed 2016-03-14 | $1.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2014-03-31 | $1.00K 10-Q · filed 2015-05-11 | $1.00K derived: sum of 2 quarters · filed 2016-03-14 | $1.00K derived: sum of 3 quarters · filed 2016-03-14 | $1.00K derived: sum of 4 quarters · filed 2016-03-14 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $0.00 derived: sum of 2 quarters · filed 2016-03-14 | $0.00 derived: sum of 3 quarters · filed 2016-03-14 | $1.00K 10-K · filed 2016-03-14 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-11-06 | $1.00K 10-Q · filed 2014-11-06 | $7.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.00K 10-Q · filed 2014-08-07 | $7.00K derived: sum of 3 quarters · filed 2015-03-13 | $7.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $1.00K 10-Q · filed 2014-05-08 | $7.00K derived: sum of 2 quarters · filed 2015-03-13 | $7.00K derived: sum of 3 quarters · filed 2015-03-13 | $7.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $6.00K derived: sum of 2 quarters · filed 2015-03-13 | $6.00K derived: sum of 3 quarters · filed 2015-03-13 | $9.00K 10-K · filed 2015-03-13 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $3.00K 10-Q · filed 2013-11-08 | -$1.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $3.00K 10-Q · filed 2013-08-09 | -$1.00K derived: sum of 3 quarters · filed 2014-03-17 | $2.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $3.00K 10-Q · filed 2013-05-09 | -$1.00K derived: sum of 2 quarters · filed 2014-03-17 | $2.00K derived: sum of 3 quarters · filed 2014-03-17 | $7.00K derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | -$4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | -$1.00K derived: sum of 2 quarters · filed 2014-03-17 | $4.00K derived: sum of 3 quarters · filed 2014-03-17 | $9.00K 10-K · filed 2014-03-17 |
| 2011-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $8.00K derived: sum of 2 quarters · filed 2012-11-06 | $13.00K 10-Q · filed 2012-11-06 | $18.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $10.00K 10-Q · filed 2012-08-03 | $15.00K derived: sum of 3 quarters · filed 2013-03-07 | $21.00K derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | $5.00K 10-Q · filed 2012-05-08 | $10.00K derived: sum of 2 quarters · filed 2013-03-07 | $16.00K derived: sum of 3 quarters · filed 2013-03-07 | |
| 2010-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $11.00K derived: sum of 2 quarters · filed 2013-03-07 | $22.00K 10-K · filed 2013-03-07 | |
| 2010-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $17.00K 10-Q · filed 2011-11-08 | ||
| 2010-06-30 | $11.00K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $28.00K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |